Lung Cancer 2000; 29 (Supl 1): 90 (abstr 293).Paesmans M, Berghmans T, Vallot F, et al. Treatment with or without chemotherapy for locally advanced non small cell lung cancer (NSCLC): a systematic review by the European Lung Cancer Working Party. Lung Cancer 2000; 29 (Supl 1): 90...
参考文献: [1]Yasushi Goto, et al. TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) in advanced non-small cell lung cancer (aNSCLC). 2023 ASCO. Abstract 9004. [2]Inamura K, Yokouchi Y, Kobayashi M, et al. ...
[5]Fossella FV,DeVore R,Kerr RN,et al.Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.The TAX 320 Non-Small Cell Lung Cancer Study Group.J Clin Oncol.200...
[9]1505TiP-TROPION-Lung07: A phase III trial of datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy in advanced/metastatic (a...
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy. Medical management is often associated wit
Presently, chemotherapy is getting replaced with that of targeted therapy, considered to be more accurate in its targeting and attacking cancerous cells. Radiation therapy: This procedure is used mainly in three cases. Prior to performing surgery, this therapy is used for shrinking size of the ...
[5] Johnson BE, Grayson J, Makuch RW, et al.: Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol 8 (3): 396-401, 1990. [6] Fry WA, Menck HR, Winchester DP: The National Cancer Data Base report ...
Ivonescimab combined with chemotherapy in patients with EGFR-mutant non-squamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 trial.
Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer 45, S253–257 (2004). Article PubMed Google Scholar Heon, S. et al. Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib ...
Obviously I’m upset by this news, but I’m also scared of having my final months ruined by side effects of chemotherapy. I’ve already gotten to see my grandchildren born and traveled extensively after retirement. I’m thinking of just going without treatment so I can enjoy the last of ...